Tiange Cu
Researcher involved in analytical validation of personalized circulating tumor DNA assay.
Best podcasts with Tiange Cu
Ranked by the Snipd community
Mar 20, 2024 • 3min
Analytical Validation of an Ultra-sensitive Personalized Circulating Tumor DNA Assay: NeXT Personal®
Researchers discuss the analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay. The assay accurately identifies tumor-specific variants for treatment monitoring and recurrence detection using whole genome sequencing.
